BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19348872)

  • 1. Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.
    Larsson M; Farde L; Hummel T; Witt M; Lindroth NE; Bäckman L
    Neuroscience; 2009 Jun; 161(2):422-6. PubMed ID: 19348872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the striatal dopamine transporter in cognitive aging.
    Erixon-Lindroth N; Farde L; Wahlin TB; Sovago J; Halldin C; Bäckman L
    Psychiatry Res; 2005 Jan; 138(1):1-12. PubMed ID: 15708296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.
    Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
    Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related decline in dopamine transporter in human brain using PET with a new radioligand [¹⁸F]FE-PE2I.
    Shingai Y; Tateno A; Arakawa R; Sakayori T; Kim W; Suzuki H; Okubo Y
    Ann Nucl Med; 2014 Apr; 28(3):220-6. PubMed ID: 24385293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
    Liu SY; Wu JJ; Zhao J; Huang SF; Wang YX; Ge JJ; Wu P; Zuo CT; Ding ZT; Wang J
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1448-53. PubMed ID: 26559130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study.
    Leroy C; Karila L; Martinot JL; Lukasiewicz M; Duchesnay E; Comtat C; Dollé F; Benyamina A; Artiges E; Ribeiro MJ; Reynaud M; Trichard C
    Addict Biol; 2012 Nov; 17(6):981-90. PubMed ID: 21812871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function.
    Troiano AR; Schulzer M; de la Fuente-Fernandez R; Mak E; McKenzie J; Sossi V; McCormick S; Ruth TJ; Stoessl AJ
    Synapse; 2010 Feb; 64(2):146-51. PubMed ID: 19852071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.
    Saba W; Valette H; Schöllhorn-Peyronneau MA; Coulon C; Ottaviani M; Chalon S; Dolle F; Emond P; Halldin C; Helfenbein J; Madelmont JC; Deloye JB; Guilloteau D; Bottlaender M
    Synapse; 2007 Jan; 61(1):17-23. PubMed ID: 17068778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.
    Braga-Neto P; Felicio AC; Hoexter MQ; Pedroso JL; Dutra LA; Alessi H; Minett T; Santos-Galduroz RF; da Rocha AJ; Garcia LA; Bertolucci PH; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2012 Aug; 18(7):854-8. PubMed ID: 22575233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression.
    Moriya H; Tiger M; Tateno A; Sakayori T; Masuoka T; Kim W; Arakawa R; Okubo Y
    Psychiatry Clin Neurosci; 2020 Aug; 74(8):424-430. PubMed ID: 32363761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
    Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.
    Wagner AK; Scanlon JM; Becker CR; Ritter AC; Niyonkuru C; Dixon CE; Conley YP; Price JC
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1328-39. PubMed ID: 24849661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
    Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
    Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.
    Stehouwer JS; Daniel LM; Chen P; Voll RJ; Williams L; Plott SJ; Votaw JR; Owens MJ; Howell L; Goodman MM
    J Med Chem; 2010 Aug; 53(15):5549-57. PubMed ID: 20597489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sex on aging-related decline of dopamine transporter in healthy subjects.
    Shin S; Nam HY; Lee MJ; Pak K; Kim K; Kim IJ
    Ann Nucl Med; 2021 Jan; 35(1):76-82. PubMed ID: 33052524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
    Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
    J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.